Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study
- PMID: 21998210
- PMCID: PMC3236117
- DOI: 10.1182/blood-2011-04-347559
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study
Abstract
The associations between immune-related conditions and multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS) have previously been investigated with inconsistent results. In a large population-based study, we identified 19 112 patients with MM, 5403 patients with MGUS, 96 617 matched control subjects, and 262 931 first-degree relatives. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) for the association of MM and MGUS with immune-related conditions by use of logistic regression. A personal history of all infections combined was associated with a significantly increased risk of MM (OR = 1.2; 95% CI, 1.1-1.3), and a personal history of all conditions in the categories infections (OR = 1.6; 95% CI, 1.5-1.7), inflammatory conditions (OR = 1.4; 95% CI, 1.2-1.5), and autoimmune diseases (OR = 2.1; 95% CI, 1.9-2.4) was associated with a significantly increased risk of MGUS. Several specific immune-related conditions elevated the risk of MM and/or MGUS. A family history of autoimmune disease was associated with a significantly increased risk of MGUS (OR = 1.1; 95% CI, 1.00-1.2), but not MM. Our findings suggest that immune-related conditions and/or their treatment are of importance in the etiology of MGUS and possibly MM. The association of both personal and family history of autoimmune disease with MGUS indicates the potential for shared susceptibility for these conditions.
Similar articles
-
History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.Ann Hematol. 2017 Feb;96(2):261-269. doi: 10.1007/s00277-016-2859-8. Epub 2016 Nov 2. Ann Hematol. 2017. PMID: 27807648 Free PMC article.
-
Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance.Front Immunol. 2022 Apr 28;13:876271. doi: 10.3389/fimmu.2022.876271. eCollection 2022. Front Immunol. 2022. PMID: 35572590 Free PMC article. Review.
-
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.Eur J Haematol. 2021 Mar;106(3):380-388. doi: 10.1111/ejh.13563. Epub 2020 Dec 28. Eur J Haematol. 2021. PMID: 33295006 Free PMC article.
-
Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.Int J Cancer. 2006 Jun 15;118(12):3095-8. doi: 10.1002/ijc.21745. Int J Cancer. 2006. PMID: 16395700
-
Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.Ann Hematol. 2021 Apr;100(4):855-863. doi: 10.1007/s00277-021-04400-7. Epub 2021 Jan 8. Ann Hematol. 2021. PMID: 33416902 Free PMC article.
Cited by
-
Multiple Myeloma: What Do We Do About Immunodeficiency?J Cancer. 2019 Apr 3;10(7):1675-1684. doi: 10.7150/jca.29993. eCollection 2019. J Cancer. 2019. PMID: 31205523 Free PMC article. Review.
-
Familial associations of monoclonal gammopathy of unknown significance with autoimmune diseases.Leukemia. 2016 Aug;30(8):1766-9. doi: 10.1038/leu.2016.43. Epub 2016 Feb 29. Leukemia. 2016. PMID: 26975726 No abstract available.
-
Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditions.Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):194-7. doi: 10.1016/j.clml.2013.02.002. Epub 2013 Mar 7. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23473950 Free PMC article. Review.
-
Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study.Blood Adv. 2017 Nov 1;1(24):2186-2192. doi: 10.1182/bloodadvances.2017007609. eCollection 2017 Nov 14. Blood Adv. 2017. PMID: 29296866 Free PMC article.
-
Inherited genetic susceptibility to multiple myeloma.Leukemia. 2014 Mar;28(3):518-24. doi: 10.1038/leu.2013.344. Epub 2013 Nov 19. Leukemia. 2014. PMID: 24247655 Review.
References
-
- Swerdlov S, Campo E, Harris N, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC; 2008.
-
- Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21–33. - PubMed
-
- Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346(8):564–569. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical